Peptidomimetics in cancer targeting

Peptidomimetics in cancer targeting

Abstract The low efficiency of treatment strategies is one of the main obstacles to developing cancer inhibitors. Up to now, various classes of therapeutics have been developed to inhibit cancer progression. Peptides due to their small size and easy production compared to proteins are highly regarde...

Full description

Bibliographic Details
Main Authors: Mohammad Mahmoudi Gomari, Shadi Abkhiz, Taha Ghantab Pour, Ehsan Lotfi, Neda Rostami, Fatemeh Nafe Monfared, Babak Ghobari, Mona Mosavi, Behruz Alipour, Nikolay V. Dokholyan
Format: Article
Language:English
Published: BMC 2022-12-01
Series:Molecular Medicine
Subjects:
Peptidomimetic
Angiogenesis
Nanoparticles
Drug resistance
Metastasis
Apoptosis
Online Access:https://doi.org/10.1186/s10020-022-00577-3

Internet

https://doi.org/10.1186/s10020-022-00577-3

Similar Items